NEW YORK – Osteoporosis diagnostic firm Osteolabs announced Wednesday that it has entered into a strategic partnership with Swiss medical laboratory Labor Team to distribute Osteolabs' test for ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK – Linear Diagnostics has been awarded £1 million ($1.36 million) from the UK's National Institute for Health and Care Research to support development of a rapid diagnostic platform and a test ...

NEW YORK – Diasorin said Saturday that it has received US Food and Drug Administration 510(k) marketing clearance for a syndromic panel to detect and identify the Gram-positive causes of bloodstream ...

The work will focus on addressing unmet needs in breast cancer, including the diagnosis and treatment of patients with rare cancer subtypes.

The protein biomarker-based test will be used to identify patients at high risk of cancer in order to prioritize them for conventional cancer screening methods.

Called Velo, the system can perform true PCR testing in 10 minutes or less and is intended for use in decentralized spaces.

The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

A new study found that women who received mail-in self-collection kits participated in screening at much higher rates than those who just received a telephone reminder.